Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Prostate Cancer Test Deal Forged by Minomic, Cirrus Dx

Prostate Cancer Test Deal Forged by Minomic, Cirrus Dx

Feb 14, 2019
|
staff reporter

NEW YORK (360Dx) — Minomic announced today that it has signed an agreement to offer its MiCheck prostate cancer diagnostic in the US through Rockville, Maryland-based CLIA laboratory Cirrus Dx.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

What's Popular?

In Cancer

  1. Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx

    Premium

  2. Roche Elecsys Anti-p53 Test for Cancer Diagnosis Earns CE Mark

  3. Nucleix Raises $55M in Financing Round

  4. Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.